Johnson & Johnson announced sales of $63.7 billion for fiscal 2008, an increase of 4.3% over 2007. Operational growth was 1.9% with currency contributing 2.4%. Domestic sales decreased 0.4%, while international sales increased 9.7%, reflecting operational growth of 4.6%—despite a 4.9% fourth-quarter decline of worldwide sales in the fourth quarter.
According to the company, sales results reflect the strong performance of the Neutrogena, Aveeno and Clean & Clear skin care lines—as well as sales from the recently completed acquisition of Dabao, the leading moisturizer in China.
Additional information is here.
